Lilly reports on new beta3-adrenergic receptor agonists as potential antiobesity agents Sep. 27, 2006
Distinct preclinical activity for PPARgamma partial agonist SVT-002149 as compared to rosiglitazone Sep. 27, 2006
Preclinical and clinical antidiabetic and antiobesity efficacy of the GLP-1 analogue liraglutide Sep. 26, 2006
Preclinical characterization and pharmacokinetics of the novel DPP-IV inhibitor GRC-8011 Sep. 26, 2006
RSS